Healthcare -
Biotechnology - NASDAQ - NL
$ 10.295
-27.8 %
$ 563 M
Market Cap
-2.33
P/E
CASH FLOW STATEMENT
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
uniQure N.V.
| Net Income | -240 M |
| Depreciation & Amortization | 12.6 M |
| Capital Expenditures | -3.37 M |
| Stock-Based Compensation | 22.3 M |
| Change in Working Capital | 0 |
| Others | 19.5 M |
| Free Cash Flow | -186 M |
Cash Flow
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||||
| Net Income | (239.6) | (308.5) | (126.8) | 329.6 | (125.0) | (124.2) | (83.3) | (80.4) | (73.4) | (78.1) | (45.0) | (37.0) | (19.5) | (22.4) |
| Depreciation & Amortization | 12.6 | 11.9 | 8.5 | 7.3 | 10.6 | 6.7 | 12.4 | 8.3 | 6.1 | 4.9 | 1.9 | 0.7 | 0.7 | 0.8 |
| Deferred Income Tax | 2.4 | 1.9 | (1.5) | 3.2 | (16.4) | 0 | 0.2 | 0.2 | 1.1 | (0.5) | (7.3) | 3.6 | 0.6 | 0.2 |
| Stock Based Compensation | 22.3 | 35.1 | 34.2 | 25.6 | 21.8 | 17.5 | 10.7 | 10.1 | 6.2 | 8.3 | 11.5 | 2.8 | 2.3 | 1.2 |
| Other Operating Activities | 19.5 | 32.5 | (16.2) | (27.3) | (19.4) | 3.4 | (9.9) | 10.1 | (2.0) | 16.1 | 8.6 | 1.9 | 80.7 K | 0.5 |
| Change in Working Capital | 0 | 81.1 | (43.4) | (50.5) | (6.5) | (2.1) | (6.2) | (12.7) | (10.3) | 68.2 | (0.5) | 22.3 | 0.8 | (1.8) |
| Cash From Operations | (182.7) | (145.9) | (145.1) | 288.0 | (134.8) | (98.7) | (76.0) | (64.3) | (72.2) | 18.8 | (30.9) | (5.7) | (14.9) | (21.7) |
| INVESTING CASH FLOW | ||||||||||||||
| Capital Expenditures | (3.4) | (7.2) | (17.7) | (17.4) | (9.5) | (6.6) | (4.2) | (5.6) | (17.2) | (9.4) | (23.3) | (8.3) | (1.2) | (0.4) |
| Other Items | 166.3 | (198.5) | (165.0) | (49.9) | 0 | 0 | 0 | (0.6) | (0.6) | 99.5 K | (1.6) | 23.5 K | 0.1 | 0.2 |
| Cash From Investing Activities | 163.0 | (205.7) | (182.7) | (67.4) | (9.5) | (6.6) | (4.2) | (6.2) | (17.8) | (9.3) | (24.9) | (8.2) | (1.1) | (0.2) |
| FINANCING CASH FLOW | ||||||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | (53.0) | 0 | 0 | 62.5 | 0 | 0 | 14.8 | 0 | (0.1) | (0.2) | 9.3 | 25.7 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (8.6) | 362.4 | 0 | 32.4 | 0 | 6.1 | 4.8 | 4.8 | 2.6 | 2.9 | 0 | (0.8) | 1.9 | 0 |
| Cash From Financing Activities | (59.5) | 362.7 | 1.4 | 94.9 | 7.4 | 248.8 | 158.0 | 90.1 | 2.4 | 150.4 | 84.5 | 46.5 | 14.9 | 0.1 |
| CHANGE IN CASH | ||||||||||||||
| Net Change In Cash | (84.2) | 13.4 | (328.2) | 311.7 | (133.0) | 143.4 | 75.5 | 26.9 | (89.1) | 164.3 | 35.8 | 32.5 | (1.1) | (21.7) |
| FREE CASH FLOW | ||||||||||||||
| Free Cash Flow | (186.1) | (153.1) | (162.7) | 270.5 | (144.3) | (105.3) | (80.3) | (69.9) | (89.4) | 9.4 | (54.2) | (14.0) | (16.2) | (22.1) |